Yes, several interleukins are employed in cancer therapy. IL-2 has been approved by the FDA for the treatment of metastatic melanoma and renal cell carcinoma. Clinical trials are ongoing to evaluate the efficacy of other interleukins like IL-12 and IL-15 in various cancers. These therapies aim to boost the body's immune response to target and destroy cancer cells more effectively.
